Director of the Center. Gamalei Alexander Gunzburg. Archive photo MOSCOW, January 5 A nasal vaccine against coronavirus and a vaccine for children of all ages should become available in 2022, Alexander Gunzburg, director of the Gamaleya Center for Epidemiology and Microbiology, told RIA Novosti. about what vaccines developed at the center can be expected in 2022.
& # 34; First of all, the nasal vaccine should become available & # 34 ;, — said Gunzburg.
At the end of the year, according to him , it is planned to conduct clinical trials of a prophylactic drug that immediately protects against influenza and coronavirus. «I think that next year the vaccine will become available for all children — those who wish, of course — vaccination will be absolutely voluntary. And this is very important,» he said. Gunzburg: Several vaccines against COVID-19, developed at the Gamalea Center, are currently registered in Russia. In August 2020, a registration certificate was issued for Sputnik V. In May 2021, it became known about the registration of the Sputnik Light vaccine, and in November the Sputnik M vaccine for adolescents was approved. 
The developer stated on the effectiveness of the nasal «Sputnik» against the «omicron»